Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes?

MLA

Lounici Boudiaf, A., et al. “Could ZnT8 Antibodies Replace ICA, GAD, IA2 and Insulin Antibodies in the Diagnosis of Type 1 Diabetes?” Current Research in Translational Medicine, vol. 66, no. 1, Mar. 2018, pp. 1–7. EBSCOhost, https://doi.org/10.1016/j.retram.2018.01.003.

APA

Lounici Boudiaf, A., Bouziane, D., Smara, M., Meddour, Y., Haffaf, E. M., Oudjit, B., Chaib Mamouzi, S., & Aouichat Bouguerra, S. (2018). Could ZnT8 antibodies replace ICA, GAD, IA2 and insulin antibodies in the diagnosis of type 1 diabetes? Current Research in Translational Medicine, 66(1), 1–7. https://doi.org/10.1016/j.retram.2018.01.003

Chicago

Lounici Boudiaf, A, D Bouziane, M Smara, Y Meddour, E M Haffaf, B Oudjit, S Chaib Mamouzi, and S Aouichat Bouguerra. 2018. “Could ZnT8 Antibodies Replace ICA, GAD, IA2 and Insulin Antibodies in the Diagnosis of Type 1 Diabetes?” Current Research in Translational Medicine 66 (1): 1–7. doi:10.1016/j.retram.2018.01.003.